The Asia-Pacific AI in clinical trials market, valued at USD 1.40 billion in 2025, is projected to reach USD 1.61 billion in 2026 and USD 5.07 billion by 2035, with a CAGR of 13.6% during the forecast period, from 2026 to 2035. For instance, in March 2025, AstraZeneca invested USD 2.5 billion in a new strategic R&D center in Beijing, supported by an AI and data science laboratory, designed to advance early-stage research and clinical development. In June 2026, HistoIndex and D&D Pharmatech annou...

The global electronic health records market, valued at USD 41 billion in 2025, is projected to reach USD 45 billion in 2026 and USD 92 billion by 2035, representing a CAGR of 8.3% during the forecast period from 2026 to 2035. Healthcare delivery is becoming increasingly data-driven, and electronic health records (EHR) have emerged as the digital backbone of this transformation. Modern EHR platforms are no longer limited to replacing paper charts; they serve as centralized clinical information sy...

The global Smart Hospitals market is expected to rise from USD 15 billion in 2026 to reach USD 160 billion by 2040, growing at a CAGR of 18.4% over the forecast period 2026 to 2040, driven by rise in connected inpatient-room modernization. Based on technology / integration layer, EHR-integrated room systems capture 24.0% market share in 2026, whereas AI and computer vision analytics register a 24.4% CAGR through 2040, driven by real-time sensing and autonomous clinical documentation. Based on ap...

The North America pharma cloud services market, valued at USD 5.7 billion in 2025, is projected to reach USD 6.8 billion in 2026 and USD 21.2 billion by 2035, representing a CAGR of 13.5% during the forecast period from 2026 to 2035. Pharmaceutical companies in North America are increasingly adopting AI-enabled cloud platforms to accelerate drug discovery, clinical development, regulatory documentation, manufacturing, and commercial operations. As pharma companies handle large volumes of genomic...

The global cloud based drug discovery platforms market, valued at USD 3.7 billion in 2025, is projected to reach USD 4.2 billion in 2026 and USD 11.4 billion by 2035, representing a CAGR of 11.7% during the forecast period 2026 to 2035. Cloud based drug discovery platforms are centralized, internet-hosted software ecosystems that provide scalable computing power, data storage, and advanced analytics tools to accelerate the discovery of new therapeutic compounds. According to our projections, Nor...

The global AI in clinical trials market, valued at USD 3.48 billion in 2025, is projected to reach USD 3.96 billion in 2026 and USD 11.61 billion by 2035, representing a CAGR of 12.7% during the forecast period 2026 to 2035. Based on the deployment mode, cloud-based AI solutions capture the largest share (around 75%) of the current market, and the trend is unlikely to change in the future. In terms of therapeutic areas, oncological disorders are expected to hold the largest market share (more th...

The global big data in healthcare market, valued at USD 93 billion in 2025, is projected to reach USD 110 billion in 2026 and USD 540 billion by 2035, with a 19.37% CAGR during the forecast period 2026 to 2035. The geographical regions segment highlights the distribution of big data in healthcare market across various geographies, such as North America, Europe, Asia, Latin America, Middle East and North Africa, and rest of the world regions. According to our projections, the big data analytic...

The global teleradiology services market, valued at USD 9.2 billion in 2025, is projected to reach USD 10.1 billion in 2026 and USD 23.3 billion by 2035, representing a CAGR of 9.7% during the forecast period 2026 to 2035. In terms of imaging modality, CT scan accounted for 35% of market revenues in 2026.With respect to end user, hospitals (51%) dominate the current market.

The global stroke AI market is expected to rise from USD 0.44 billion in 2026 to reach USD 8.05 billion by 2040, growing at a CAGR of 23.1% over the forecast period 2026 to 2040, driven by time-critical stroke detection, care-team activation, and automated treatment-routing workflows. Based on offering, AI imaging and triage software captures 47.0% market share in 2026, whereas analytics and performance-management services register a 28.4% CAGR through 2040, driven by outcomes tracking. Based on...

The global AI in medical scribing market reached USD 1.82 billion in 2026 and is projected to reach USD 22.3 billion by 2040, growing at a CAGR of 19.6% over the forecast period 2026 to 2040, driven by clinician burnout reduction and EHR-native ambient documentation. Ambient clinical documentation is moving from transcription replacement to EHR-integrated clinical workflow automation. Hospitals first bought AI medical scribe software to reduce note burden and after-hours charting.

The global triage system market is estimated at USD 9.8 billion in 2026 and is projected to reach USD 42.2 billion by 2040, growing at a CAGR of 11.0% over the forecast period 2026 to 2040, driven by AI-enabled emergency department prioritization, virtual front-door triage, and EHR-integrated decision-support tools. Regulatory classification and workflow validation slow adoption because triage tools influence patient routing and clinical prioritization. Infermedica’s September 2025 MDR Class I...

The global AI in medical coding market is expected to rise from USD 3.4 billion in 2026 and reach USD 16.2 billion by 2040, growing at a CAGR of 11.8% over the forecast period 2026 to 2040, driven by revenue cycle automation and coder productivity pressure. Based on Component, Software platforms is both the dominant and fastest-growing category, holding 72.0% share in 2026 and expanding at 12.4% CAGR through 2040, driven by scalable autonomous coding engines. Compliance exposure restrains autono...

The global clinical workflow solutions market is expected to rise from USD 14.8 billion in 2026 to reach USD 71.7 billion by 2040, growing at a CAGR of 11.9% over the forecast period 2026 to 2040, driven by EHR-integrated automation, cloud deployment, and AI-enabled documentation. The clinical workflow solutions market is shifting from fragmented messaging and data tools into AI-enabled operating layers. Hospitals now need platforms that connect EHR data, alerts, documentation, orders, analytics...

The global connected medical device cybersecurity market reached USD 9.7 billion in 2026 and is projected to reach USD 50.0 billion by 2040, growing at a CAGR of 12.43% over the forecast period 2026 to 2040, driven by rising IoMT exposure, FDA cybersecurity requirements, and hospital network risk. Based on geography, North America captures 42.0% market share in 2026, whereas Asia-Pacific registers a 14.9% CAGR through 2040, driven by hospital digitization and regulatory catch-up. Based on applic...

The quantum computing in drug discovery market, valued at USD 315 million in 2025, is projected to reach USD 361 million in 2026 and USD 1,692 million by 2035, representing a CAGR of 18.7% during the forecast period 2026 to 2035. In terms of geographical regions, North America captures more than 40% of the market value in the year 2026, due to its strong public and private investments, supportive regulations, and significant funding. In February 2026, XtalPi entered into a collaboration with VIS...

The global AI-Powered claim denial management market is expected to rise from USD 1.35 billion in 2026 and is projected to reach USD 15.0 billion by 2040, growing at a CAGR of 18.8% over the forecast period 2026 to 2040, driven by rising claim denials and payer-policy complexity. Based on geography, North America captures 47.0% market share in 2026, whereas Asia-Pacific registers a 22.6% CAGR through 2040, driven by public claims digitization.

The cloud computing market, valued at USD 818 billion in 2025, is projected to grow to USD 950 billion in 2026 and USD 5,608 billion by 2040, representing a CAGR of 13.52% during the forecast period. The high demand for flexible and cost-effective IT solutions has led to a shift from conventional on-premises systems to cloud-based services, enhancing efficiency and minimizing operational costs. This shift reduces the need for extensive physical hardware and maintenance, allowing businesses t...

The global pharma cloud services market, valued at USD 10.8 billion in 2025, is projected to reach USD 13.0 billion in 2026 and USD 42.9 billion by 2035, representing a CAGR of 14.2% during the forecast period 2026 to 2035. In terms of area of application, drug discovery holds the highest share (nearly 50%) of the market. In terms of end user, pharmaceutical and life science companies hold the highest share (65%) of the current market. In terms of geographical regions, North America holds the hi...

The global AI in drug manufacturing market is estimated to grow from USD 0.9 billion in 2025 to reach USD 1.2 billion in 2026 and USD 34.8 billion by 2040, representing a CAGR of 27.2% during the forecast period 2026 to 2040. In June 2025, Aizon entered into a partnership with Sequence aimed at delivering comprehensive, AI-powered solutions for the pharmaceutical industry. Based on the type of AI solution, the global market includes standard / off-the-shelf AI solutions and personalized AI solut...

The remote patient monitoring market is estimated to grow from USD 7.2 billion in 2024 to reach USD 9.4 billion in 2025 and USD 88.0 billion by 2035, representing a higher CAGR of 25% during the forecast period. Notably, as per a report published by the Centers for Disease Control and Prevention in 2024, nearly 129 million people in the United States are suffering from at least one chronic disease. As the global demand of user-friendly, cost-effective and efficient data tracking devices increase...